Showing 1 - 20 results of 67,481 for search '(( 50 ((ms decrease) OR (_ decrease)) ) OR ((( _ linear decrease ) OR ( i mean decrease ))))*', query time: 0.93s Refine Results
  1. 1
  2. 2
  3. 3

    Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

    Published 2014
    “…Leisure bouts, drawn from the mode, do not change by much. Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”
  4. 4

    Appendix E. Log-linear decrease of overall mean pathogen incidence. by Tanja Rottstock (458761)

    Published 2016
    “…Log-linear decrease of overall mean pathogen incidence.…”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

    Published 2025
    “…These mice exhibited a minimal change in noise-evoked PPy activity when comparing the first and second week of imaging (2-way ANOVA, F = 1.79, <i>p</i> = 0.11, post hoc baseline w1 50 dB: baseline w2 50 dB <i>p</i> = 1 Bonferroni corrected, nested ANOVA (mouse nested within session) F = 1.76, <i>p</i> = 0.12, mean ± SE). …”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Factors associated with decreased FVC by multiple linear regression analysis. by Eun Kyung Jang (732099)

    Published 2015
    “…<p>R<sup>2</sup> =. 39</p><p>Factors associated with decreased FVC by multiple linear regression analysis.…”
  17. 17
  18. 18
  19. 19

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
  20. 20

    Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1. by Rajesh Jayachandran (542641)

    Published 2014
    “…Scale bar, 2 microns. Data shown are mean values ± SD, <i>p</i><0.01. (C) Hippocampal neurons were labeled using anti-vGLUT1 and anti-vGAT antibodies, followed by Alex Fluor 488 or 568 labeled secondary antibodies, respectively. …”